IL1B and Parkinson disease: Previous studies have consistently demonstrated that chronic IL-1β signaling accelerates dopaminergic neuronal loss in both toxin-induced and genetic PD models (e.g., MPTP, rotenone models), supporting its direct pathogenic contribution [46].